Evidence map›Paper›PMID 24829474›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2014

Pancreatic β-cell proliferation in obesity.

Amelia K Linnemann, Mieke Baan, Dawn Belt Davis

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Investigating the Pathogenesis and Treatment of Type 2 Diabetes from the Perspective of Adipose Tissue.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.International journal of molecular sciences · 2024
    Review
  18. Article
  19. β-Cell Regeneration Is Driven by Pancreatic Plasticity.Advances in anatomy, embryology, and cell biology · 2024
    Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Amelia K LinnemannDivision of Endocrinology, Department of Medicine, and.
Mieke BaanDivision of Endocrinology, Department of Medicine, and School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI; and.
Dawn Belt DavisDivision of Endocrinology, Department of Medicine, and William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin dbd@medicine.wisc.edu.
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

Comparative Biomedical Sciences Training ProgramT32OD010423 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Marulasiddappa Suresh · 2012 to 2026
$5.0M
Comparative Biomedical Sciences Training ProgramT32RR023916 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI CZUPRYNSKI, CHARLES JOSEPH · 2007 to 2011
$1.2M
Mechanisms of Beta Cell Proliferation in Mouse and Human IsletsK08DK083442 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI DAVIS, DAWN B · 2009 to 2013
$701k
Transcriptional Regulation of Pancreatic Beta Cell MassI01BX001880 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI DAVIS, DAWN B · 2013 to 2016
–
BLRD VA I01 BX001880NCRR NIH HHS T32 RR023916NIDDK NIH HHS DK083442NIDDK NIH HHS K08 DK083442NIH HHS OD010423NIH HHS T32 OD010423
6 · The paper itself

Abstract

Because obesity rates have increased dramatically over the past 3 decades, type 2 diabetes has become increasingly prevalent as well. Type 2 diabetes is associated with decreased pancreatic β-cell mass and function, resulting in inadequate insulin production. Conversely, in nondiabetic obesity, an expansion in β-cell mass occurs to provide sufficient insulin and to prevent hyperglycemia. This expansion is at least in part due to β-cell proliferation. This review focuses on the mechanisms regulating obesity-induced β-cell proliferation in humans and mice. Many factors have potential roles in the regulation of obesity-driven β-cell proliferation, including nutrients, insulin, incretins, hepatocyte growth factor, and recently identified liver-derived secreted factors. Much is still unknown about the regulation of β-cell replication, especially in humans. The extracellular signals that activate proliferative pathways in obesity, the relative importance of each of these pathways, and the extent of cross-talk between these pathways are important areas of future study.

Indexed as

Cell ProliferationAnimalsDiabetes Mellitus, Type 2Diet, High-FatDisease Models, AnimalHepatocytesHumansHyperglycemiaInsulin ResistanceInsulin-Secreting CellsLiverObesityReceptors, G-Protein-CoupledReceptors, G-Protein-Coupled

Identifiers

PMID24829474
PMCPMC4013180
OpenAlexW2161222424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.